Ultrasound estimation of pleural fluid volume is a core procedural skill for thoracentesis and chest tube placement, making this directly relevant to IP practice.
Abstract
WHAT IS ALREADY KNOWN ON THIS TOPIC In pleural infection, the RAPID score is the only robustly prospective validated risk stratification tool and accurately predicts overall 3-month mortality. However, evidence supporting its performance across different healthcare settings in different populations and its relationship with other clinically important outcomes has not been studied before. WHAT THIS STUDY ADDS This systematic review and meta-analysis of 2839 patients from nine independent cohorts confirms that the RAPID score reliably stratifies all-cause 3-month mortality across diverse populations and is associated with progressively longer hospital stay. In contrast, RAPID risk category was not consistently associated with the escalation to intrapleural enzyme therapy or surgical intervention, suggesting that the score is better suited for prognostic risk stratification than for guiding treatment decisions. These findings support the use of the RAPID score for early prognostic assessment while highlighting the need for prospective multicentre clinical feasibility trial evaluating RAPID-guided...
Keep reading
N opens the next oneDirectly impacts pleural management and staging by maximizing the diagnostic yield of routine thoracentesis for molecular testing in malignancy.
Pleural fluid obtained during thoracentesis or medical thoracoscopy should be preserved for cfDNA molecular testing when tissue is limited.
Relevant to pleural disease management and post-procedural care of trapped or non-expandable lungs.
Provides useful risk stratification tools for managing secondary spontaneous pneumothorax patients who often require IP intervention.
Relevant for multidisciplinary management of malignant pleural mesothelioma, though radiotherapy is primarily managed by radiation oncology.